Hematological Biobank is owned by the Finnish Association of Hematology, Institute for Molecular Medicine Finland and Finnish Red Cross Blood Service. The Association of Finnish Cancer Patients is also involved in Hematological Biobank. Biobanks’s research area covers the prevention, diagnosis, treatment and follow-up of hematological disorders. Hematological Biobank is a national biobank and collects samples and data from patients with hematological disorder in all Finnish hematological units that have made an agreement on sample collection. The aim of the Hematological Biobank is to collect a comprehensive and high quality sample and data repository for hematology research. The Hematological Biobank was registered in Valvira’s (National Supervisory Authority for Welfare and Health) national biobank registry on July 15, 2014.